533 Survival mechanisms common to immunotherapy and drug tolerant persister tumor cells

• Marcela Maus,
• Anthony Letai,
• Cloud Paweletz,
• Michael Olson,
• Maria Davern,
• David Barbie,
• Brenda Chan,
• Lara Bencsics,
• Jasmine Yun-Tong Kung,
• Michael Yorsz,
• Gabriella Stone,
• Patrick Lizotte,
• Patrick Bhola

Affiliations

Marcela Maus

11Massachusetts General Hospital, Boston, MA, USA

Anthony Letai

Aff271 grid.65499.370000000121069910Dana-Farber Cancer Institute Boston MA USA

Cloud Paweletz

Belfer Center for Applied Cancer Research, Dana-Farber Cancer Institute Hospital, Boston, Massachusetts, USA

Michael Olson

2Harvard Medical School, Boston, MA, USA

Maria Davern

Trinity College Dublin, Dublin, Ireland

David Barbie

1Dana-Farber Cancer Institute, Boston, MA, USA

Brenda Chan

1Dana-Farber Cancer Institute, Boston, MA, USA

Lara Bencsics

1Dana-Farber Cancer Institute, Boston, MA, USA

Jasmine Yun-Tong Kung

2Harvard Medical School, Boston, MA, USA

Michael Yorsz

1Dana-Farber Cancer Institute, Boston, MA, USA

Gabriella Stone

1Dana-Farber Cancer Institute, Boston, MA, USA

Patrick Lizotte

1Dana-Farber Cancer Institute, Boston, MA, USA

Patrick Bhola

1Dana-Farber Cancer Institute, Boston, MA, USA